The complaint was forwarded to our parent company in germany for their evaluation.The investigation summary is as follows: we received three defective catheters as a sample, two nutriline twinflo and one nutriline.The product incident report (pir) only mentioned nutriline twinflo.All ll-hubs are connected to an external needle free connection system.Additionally, the customer forwarded us three videos of the nutriline twinflo, which show an experimental setup.According to the complaint form, blood reflux occurs when the syringe is removed, even if the extension line is closed by the clamp.Our microscopic examination of the extensions lines reveals several clamping marks.To show that the clamps seal the extension lines completely, and thus no transfer of pressure differences through the clamps is possible, we have conducted leakage tests with positive and negative pressure.All tests were performed both with and without the needle free connection system: · leak-proof in terms of overpressure: a compressed air device for leakage testing is used.The setting parameters correspond to those used during the manufacturing process.· leak-proof in terms of negative pressure: a 10 ml syringe is used to create a vacuum by retracting the piston.In addition, we measured the functional dimensions of the clamps to verify that they were within our specification.Finally, we mimicked the experimental setups from the videos but none of the experiments showed blood reflux.To demonstrate that reflux would have been visible, we took a reference image with aspirated dyed water (open clamps).A review of the batch history records was performed, and no deviations.Each catheter is flow and leak tested during production.Incoming goods inspections and two 100% visual tests after packaging are carried out.The inner and outer diameters of the extension line are monitored during production and lie within our specifications for the involved batches.There is one additional unrelated complaint for batch 8113387 and batch 8093927.There is no additional complaint regarding blood reflux in code 4g07125223.No further corrective action has been initiated by quality management at this time as no defect has been identified.Corrective action: no further corrective action has been initiated by quality management at this time as no defect has been identified.However, both vygon usa and germany will continue to monitor this issue.
|